NEW YORK (Reuters Health) – Adding myo-inositol supplementation to diet therapy improves components of metabolic syndrome in postmenopausal women better than diet alone, results of an Italian study…
NEW YORK (Reuters Health) – Children with acute diarrhea recover more quickly when treated with a hypotonic oral rehydration solution containing zinc and prebiotics than those given standard…
NEW YORK (Reuters Health) – Whether appendectomy for acute appendicitis is performed within 6 hours or more than 12 hours after admission has no clinically meaningful effect on…
NEW YORK (Reuters Health) – Patients with pulmonary hyperinflation due to advanced emphysema have a modest improvement in lung function and exercise tolerance after placement of endobronchial valves…
NEW YORK (Reuters Health) – When gynecologic surgery is performed laparoscopically, the occurrence of thromboembolism is quite rare, even in patients with gynecologic malignancy, researchers report in the…
NEW YORK (Reuters Health) – General surgery patients with elevated blood glucose levels after the operation have an increased risk of developing an infection at the surgical site,…
NEW YORK (Reuters Health) – The problem of drooling in children with neurological disorders can be relieved in about half of cases by injections of botulinum toxin into…
NEW YORK (Reuters Health) – The tyrosine-kinase inhibitor pazopanib seems to be a promising option for treating progressive metastatic differentiated thyroid cancer that is unresponsive to radioiodine therapy,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – Rates of deep vein thrombosis (DVT) in immobilized stroke patients are lower when thigh-length graduated compression stockings are used rather than below-knee stockings,…
NEW YORK (Reuters Health) – In children hospitalized with Henoch-Schönlein purpura, or HSP, corticosteroid treatment is associated with a decreased likelihood of several clinically relevant outcomes, according to…
NEW YORK (Reuters Health) – Response rates are higher when bortezomib plus dexamethasone rather than vincristine plus doxorubicin plus dexamethasone (VAD) is used as induction therapy before stem-cell…
